The results showed that ern1 expression was significantly upregulated in the NAFLD group compared with the control group (P < 0.01, Figure 10A), whereas slc11a1 expression was markedly decreased in the NAFLD group (Figure 10B). The gene discussed is ERN1; the disease is metabolic dysfunction-associated steatotic liver disease.